Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study

Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis

(2010) Pantelis A. Sarafidis et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study

(2010) Katerina K Naka et al.   Cardiovascular Diabetology

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

Herausforderung Diabetestherapie: Effekte der Glitazone jenseits der Blutzuckerkontrolle

(2009) G Schernthaner et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy

(2009) L. Monnier et al.   DIABETOLOGIA

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone

(2009) D. John Betteridge   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Markers of inflammation and coronary artery calcification: A systematic review

(2008) Yasmin S. Hamirani et al.   ATHEROSCLEROSIS

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population

(2008) Peter Garvin et al.   PLoS One